November/December 2010
Issue
Features
Are Anti-amyloid Therapies Still Worth Being Developed as Treatments for Alzheimer’s Disease?
Despite limited pharmaceutical success thus far, amyloid peptides may yet prove useful in the treatment of Alzheimer’s and delay disease progression.
By Laurent Lecanu, DPharm, PhD
Onabotulinumtoxin in the Preventive Treatment of Chronic Migraine and Other Headaches
While BoNTA shows promise in the management of chronic migraine, optimal outcomes will be acheived when clinicians learn which patients are most likely to benefit.
By Michael J Marmura, MD
Evaluation of Cervicalgia With Headache
Know how to find the cause of neck pain to establish a specific diagnosis and expedite treatment.
By Jeffrey Gehret, DO, Sanjay Yadla, MD, John K. Ratliff, MD, and Steven Mandel, MD
Top 5 Articles From December 2010
Evaluation of Cervicalgia With Headache
Know how to find the cause of neck pain to establish a specific diagnosis and expedite treatment.
By Jeffrey Gehret, DO, Sanjay Yadla, MD, John K. Ratliff, MD, and Steven Mandel, MD
Onabotulinumtoxin in the Preventive Treatment of Chronic Migraine and Other Headaches
While BoNTA shows promise in the management of chronic migraine, optimal outcomes will be acheived when clinicians learn which patients are most likely to benefit.
By Michael J Marmura, MD
Are Anti-amyloid Therapies Still Worth Being Developed as Treatments for Alzheimer’s Disease?
Despite limited pharmaceutical success thus far, amyloid peptides may yet prove useful in the treatment of Alzheimer’s and delay disease progression.
